AN1 16.7% 0.7¢ anagenics limited

AN1 Quarterly Trends, page-15

  1. 3,152 Posts.
    lightbulb Created with Sketch. 335

    Well that seals it then.

    With Maria in a strategic role at Roquefort and able to keep an eye on any deals being made I would expect that if Anagenics was in a position to ever need their own MK patents for some development they could apply to Roquefort who would then utilize Lyramids license at arms length.

    So all the ballyhoo about being sold for peanuts is mistaken.
    They still have access to all their own patents through Roquefort, Roquefort is doing the hard lifting in the meantime with MK.
    A sale by Roquefort of the whole Lyramid license and company to another party doesnt alter anything.

    IMHO
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.7¢
Change
0.001(16.7%)
Mkt cap ! $3.229M
Open High Low Value Volume
0.7¢ 0.7¢ 0.7¢ $32.31K 4.617M

Buyers (Bids)

No. Vol. Price($)
2 413225 0.7¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 615000 4
View Market Depth
Last trade - 15.54pm 20/06/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.